Search

Search Constraints

You searched for: Author/Creator Ferrarini, Manlio

Search Results

1. Alliance Against Cancer, the network of Italian cancer centers bridging research and care. Issue 1 (December 2015)

2. Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Issue 5 (24th February 2021)

3. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia. Issue 11 (2nd November 2015)

4. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens. Issue 6 (17th August 2006)

5. Chromosome 2p gain in monoclonal B‐cell lymphocytosis and in early stage chronic lymphocytic leukemia12. Issue 1 (9th October 2012)

6. Comparison between the CLL‐IPI and the Barcelona‐Brno prognostic model: Analysis of 1299 newly diagnosed cases. Issue 2 (23rd November 2017)

7. Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases. (28th January 2021)

8. Disease‐biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. Issue 4 (30th January 2019)

9. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia. Issue 3 (18th December 2013)

10. Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials. Issue 8 (3rd May 2021)